Depleting the protein ADORA2B from the blood of mice led to faster cognitive decline, decreased auditory processing, and increased brain inflammation.
YTHDF2 is a key protein that assists in creating healthy blood cells by regulating the body's inflammatory response.
PIMS-TS, a Kawasaki-like disease that affects children with COVID-19, causes changes in monocytes, a new study reports.
Gene variants in the immune system result in sex-based vulnerabilities to autoimmune diseases and schizophrenia.
Coronavirus has been linked to a higher rate of developing venous thromboembolism. A D-dimer blood test is a useful way to identify COVID-19 patients at a higher risk of venous thromboembolism.
Parkinson's disease involves monocytic alterations in the blood. The cells have reduced viability and are unresponsive to specific stimuli, which could have relevant consequences for the progression of Parkinson's. Immune modulation medications may be a new treatment option to inhibit neurodegeneration associated with PD.
Researchers have identified two new species of bacteria in the blood of patients in China. The bacterias are in the Enterobacter genus and are resistant to multiple antibiotics. Enterobacter has previously been linked to meningitis and other serious medical conditions.
Investigating 32 key nutrients in the Mediterranean diet, researcher report aging individuals with more abundant key nutrients in their blood had better functional connectivity and improved cognitive performance than those lacking the nutrients.
A groundbreaking study reveals human immune cells in the blood can be transformed into functional neurons within 3 weeks by adding four proteins. The discovery could be used to generate neurons to study specific psychological and neurological disorders, researchers say.
A new study argues against the rejuvenating properties of young blood.
A new measuring method has detected oxytocin at much higher rates in blood serum and plasma than researchers previously thought.
According to a new study, the KIR4.1 antibody may be present in patients before the onsite of multiple sclerosis.
